Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Introduction: Tat, a key HIV virulence protein, has been targeted for the development of a therapeutic vaccine aimed at cART intensification. Results from phase II clinical trials in Italy (ISS T-002) and South Africa (ISS T-003) indicated that Tat vaccination promotes increases of CD4(+) T-cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sgadari, Cecilia, Monini, Paolo, Tripiciano, Antonella, Picconi, Orietta, Casabianca, Anna, Orlandi, Chiara, Moretti, Sonia, Francavilla, Vittorio, Arancio, Angela, Paniccia, Giovanni, Campagna, Massimo, Bellino, Stefania, Meschiari, Marianna, Nozza, Silvia, Sighinolfi, Laura, Latini, Alessandra, Muscatello, Antonio, Saracino, Annalisa, Di Pietro, Massimo, Galli, Massimo, Cafaro, Aurelio, Magnani, Mauro, Ensoli, Fabrizio, Ensoli, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381398/
https://www.ncbi.nlm.nih.gov/pubmed/30815001
http://dx.doi.org/10.3389/fimmu.2019.00233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381398/
https://www.ncbi.nlm.nih.gov/pubmed/30815001
http://dx.doi.org/10.3389/fimmu.2019.00233

Ejemplares similares